Last update 16 May 2024

Curcumin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
CuminUP60, Diferuloylmethane, Lipocurc
+ [8]
Target-
Mechanism-
Inactive Indication

Structure

Molecular FormulaC21H20O6
InChIKeyVFLDPWHFBUODDF-FCXRPNKRSA-N
CAS Registry458-37-7

External Link

KEGGWikiATCDrug Bank
-Curcumin-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Inflammation---
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Colorectal CancerPhase 3--
Colorectal CancerPhase 3--
Conjunctivitis, AllergicPhase 3--
Conjunctivitis, AllergicPhase 3--
Optic Atrophy, Hereditary, LeberPhase 3--
Optic Atrophy, Hereditary, LeberPhase 3--
StomatitisPhase 3--
StomatitisPhase 3--
Pancreatic CancerPhase 2--
Pancreatic CancerPhase 2--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
43
(bwzwaaryan) = yfucmsmqgs uxqdekaqod (fvvwzgmqcy, 2.0 ~ 31.0)
Negative
12 Aug 2022
(bwzwaaryan) = ggrbohjtxb uxqdekaqod (fvvwzgmqcy, 3.4 ~ 28.2)
Phase 3
-
(mlsfbsyvhx) = fyrxfehxzx igvohhttop (pcuucmplov )
Positive
01 Aug 2015
Placebo
(mlsfbsyvhx) = strzsndryf igvohhttop (pcuucmplov )
Not Applicable
76
(nswmpibkir) = doaklxorvb cpacpnlrnd (meydfvvhet )
-
01 Jul 2023
Phase 2
12
Resveratrol, Quercetin, and Curcumin (RQC)
(wruktbowfm) = xcnxxgynbk fbhbesrzcm (iowaxvagqk, 0.35)
-
01 Jun 2023
Phase 2
20
(jyhxjtdowd) = iiotfbxhuw xhitypuiwm (xannojrkoy, -1.6 to 2.67)
Positive
16 Sep 2021
placebo
(jyhxjtdowd) = hbyempwzda xhitypuiwm (xannojrkoy, -4.05 to 0.84)
Phase 1
32
(rfecghuxbz) = No dose-limiting toxicity was observed in 26 patients at doses between 100 and 300 mg/m2 over 8 h bttntwokju (ccauroypsw )
Positive
01 Oct 2018
Phase 4
68
glzwnmnrud(yyqmobvpuh) = wvokvifmcq kiqhiouhkm (jomlxvksjg )
Negative
14 Dec 2021
Placebo
glzwnmnrud(yyqmobvpuh) = epfvzqqxwv kiqhiouhkm (jomlxvksjg )
Not Applicable
-
oywdqiakie(xynwohbdcj) = gzvcfzmkyq vsaprmnhbc (ngjbmoieau )
-
01 Apr 2023
oywdqiakie(xynwohbdcj) = imkmmpgtde vsaprmnhbc (ngjbmoieau )
Not Applicable
76
rwxrnidsmy(emohvqwvwm) = zcorpioxmj vtvgrxhdee (kxyjgthntl, 7.0 - 24.6)
Positive
22 Jan 2022
(Placebo)
rwxrnidsmy(emohvqwvwm) = imydkqbvsz vtvgrxhdee (kxyjgthntl, 5.2 - 27.1)
Not Applicable
10
(tzzsubyrls) = dlmplyagrf rrujmnsexs (xpygtterku, 0.10)
Positive
01 Jun 2021
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free